The CONTOUR®NEXT ONE BGM system (BGMS) includes a wireless-enabled BG meter that links to the CONTOUR®Diabetes app installed on a mobile device. The system, based on the IMB model, detects and reports patterns of BG readings and provides guidance for self-management. The IMB model emphasizes the need for actionable information, motivation to act, and behavioral skills for acting effectively, to strengthen self-management of diabetes. This 6-week study with 46 insulin-using individuals with diabetes assessed the BGMS with the CONTOUR®Diabetes app Version 2 Prototype. Participant appraisal of the BGM/app system was positive on multiple dimensions (Table 1). Participants strongly agreed/agreed that using this BGM/app system provided them with a better understanding of their disease (98%), helped them feel more engaged with their diabetes management program (91%), they felt more motivated to adhere to their health care provider's therapy and testing recommendations (76%), that the “My Patterns” pattern recognition feature was helpful in managing their diabetes (73%), and that they found themselves testing more frequently throughout the day (56%).


W. Fisher: Consultant; Self; Bayer AG, Ascensia Diabetes Care, Roche Diabetes Care Health and Digital Solutions. A. Stuhr: Employee; Self; Ascensia Diabetes Care. J. Wallace: Employee; Self; Ascensia Diabetes Care. S. Zhuplatov: Employee; Self; Ascensia Diabetes Care. T.S. Bailey: Research Support; Self; Abbott. Consultant; Self; Abbott. Speaker's Bureau; Self; Abbott. Research Support; Self; Ambra BioScience, Ascensia Diabetes Care, Becton, Dickinson and Company. Consultant; Self; Becton, Dickinson and Company. Research Support; Self; Boehringer Ingelheim Pharmaceuticals, Inc., Calibra Medical. Consultant; Self; Calibra Medical. Research Support; Self; Companion Medical, Dexcom, Inc., Glooko, Inc., GlySens Incorporated, Lexicon Pharmaceuticals, Inc., Eli Lilly and Company. Consultant; Self; Eli Lilly and Company. Speaker's Bureau; Self; Eli Lilly and Company. Research Support; Self; Medtronic MiniMed, Inc.. Consultant; Self; Medtronic MiniMed, Inc.. Speaker's Bureau; Self; Medtronic MiniMed, Inc.. Research Support; Self; Novo Nordisk Inc.. Consultant; Self; Novo Nordisk Inc.. Speaker's Bureau; Self; Novo Nordisk Inc.. Research Support; Self; Sanofi. Consultant; Self; Sanofi. Speaker's Bureau; Self; Sanofi. Research Support; Self; Senseonics. Consultant; Self; Intarcia Therapeutics, Inc.. Research Support; Self; Versartis, Inc., Xeris Pharmaceuticals, Inc., MannKind Corporation. S. Pardo: Employee; Self; Ascensia Diabetes Care.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at